Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 340Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

  Article Access Statistics

Year : 2018 | Volume:  9 | Issue Number:  4 | Page:  187-188

LETTER TO EDITOR

From “Glivec®” to “Prevnar 13®”: How strong is the Indian drug patenting system?
Raj Gerard Marshall

Number of times this article was viewed 139
Number of times this article has been printed  from the site 2
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal